世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

オンボディインジェクターの世界市場成長 2023-2029


Global On-body Injectors Market Growth 2023-2029

LPI(LPインフォメーション)の最新調査によると、オンボディインジェクターの世界市場規模は2022年に1億4,090万米ドルとなった。下流市場での需要拡大に伴い、オンボディインジェクターは2029年までに3億8770万... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年10月8日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
109 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、オンボディインジェクターの世界市場規模は2022年に1億4,090万米ドルとなった。下流市場での需要拡大に伴い、オンボディインジェクターは2029年までに3億8770万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは15.6%である。
この調査レポートは、世界のオンボディインジェクター市場の成長可能性を明らかにしています。オンボディインジェクターは今後の市場でも安定した成長が期待される。しかし、オンボディインジェクターの普及には、製品の差別化、コストの削減、サプライチェーンの最適化が依然として重要である。市場参加者は、オンボディ・インジェクター市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。
オンボディインジェクターは、オンボディデリバリーシステム(OBDS)としても知られ、指定された期間にわたって制御された用量の薬物または治療物質を皮下(皮膚の下)に送達するように設計された医療機器である。これらの装置は通常身体に装着し、薬物、ホルモン、生物製剤など様々な治療を行うために使用される。体内注射器には、患者の利便性の向上、服薬アドヒアランスの改善、複雑な治療法の投与能力など、いくつかの利点がある。
本レポートの対象範囲は、非インスリン型オンボディインジェクターである。
世界市場では、オンボディ注射器は、AWest Pharmaceutical Services、Insulet、Gerresheimer、ect.この業界では上位3社が市場シェアの約80%を占めている。北米、欧州、アジア太平洋地域がこの製品の主要製造地域で、いずれも世界市場シェアの約15%を占めている。同製品は、製品タイプによって電子シリンジと機械式シリンジに分類される。同製品は、腫瘍免疫学、心血管疾患、神経疾患、その他の疾患の治療に広く使用されている。
主な特徴
オンボディ注射器市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、オンボディ注射器市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(電子式インジェクター、機械式インジェクターなど)、地域別内訳などが含まれます。
市場促進要因と課題:レポートでは、政府規制、環境問題、技術進歩、消費者の嗜好の変化など、オンボディインジェクター市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制約、航続距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。
競合情勢:この調査レポートは、オンボディインジェクター市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業や市場に影響を与える可能性のある企業にもスポットを当てています。
技術開発:調査レポートは、オンボディインジェクター産業における最新の技術開発を掘り下げることができます。これには、オンボディインジェクター技術の進歩、オンボディインジェクターの新規参入、オンボディインジェクターの新規投資、オンボディインジェクターの将来を形作るその他の技術革新が含まれます。
川下企業の好み:このレポートは、オンボディインジェクター市場における顧客の購買行動と採用動向を明らかにすることができます。顧客の購買決定やオンボディインジェクター製品の嗜好に影響を与える要因も含まれる。
政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブがオンボディインジェクター市場に与える影響を分析しています。これには、オンボディインジェクター市場の促進を目的とした規制の枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境影響と持続可能性調査レポートは、オンボディインジェクター市場の環境影響と持続可能性の側面を評価します。
市場予測と将来展望:実施した分析に基づいて、調査レポートはオンボディインジェクター産業の市場予測と展望を提供します。これには、市場規模、成長率、地域別動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、オンボディインジェクター市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
オンボディインジェクター市場は、タイプ別と用途別に分類されます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
電子式インジェクター
機械式インジェクター
用途別セグメント
免疫腫瘍学
心血管疾患
神経疾患
その他
本レポートではまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ウエスト・ファーマシューティカル・サービス
インスレット
ゲレスハイマー
ユナイテッド・セラピューティクス
CCバイオ
BD
イプソメッド
イネーブルインジェクション
ネメラ
ステヴァナートグループ
ソンセボズ
ローマン治療システム
エルカム薬物送達デバイス(E3D)
本レポートで扱う主な質問
オンボディ注射器の世界市場の10年展望は?
オンボディインジェクター市場の成長を促進する世界および地域別の要因は何か?
市場別・地域別で最も急成長する技術は何か?
オンボディインジェクターの市場機会は最終市場規模によってどのように異なるのか?
オンボディインジェクターのタイプ別、用途別の内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global On-body Injectors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for On-body Injectors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for On-body Injectors by Country/Region, 2018, 2022 & 2029
2.2 On-body Injectors Segment by Type
2.2.1 Electronic Injectors
2.2.2 Mechanical Injectors
2.3 On-body Injectors Sales by Type
2.3.1 Global On-body Injectors Sales Market Share by Type (2018-2023)
2.3.2 Global On-body Injectors Revenue and Market Share by Type (2018-2023)
2.3.3 Global On-body Injectors Sale Price by Type (2018-2023)
2.4 On-body Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Cardiovascular Diseases
2.4.3 Neurological Diseases
2.4.4 Others
2.5 On-body Injectors Sales by Application
2.5.1 Global On-body Injectors Sale Market Share by Application (2018-2023)
2.5.2 Global On-body Injectors Revenue and Market Share by Application (2018-2023)
2.5.3 Global On-body Injectors Sale Price by Application (2018-2023)
3 Global On-body Injectors by Company
3.1 Global On-body Injectors Breakdown Data by Company
3.1.1 Global On-body Injectors Annual Sales by Company (2018-2023)
3.1.2 Global On-body Injectors Sales Market Share by Company (2018-2023)
3.2 Global On-body Injectors Annual Revenue by Company (2018-2023)
3.2.1 Global On-body Injectors Revenue by Company (2018-2023)
3.2.2 Global On-body Injectors Revenue Market Share by Company (2018-2023)
3.3 Global On-body Injectors Sale Price by Company
3.4 Key Manufacturers On-body Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-body Injectors Product Location Distribution
3.4.2 Players On-body Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for On-body Injectors by Geographic Region
4.1 World Historic On-body Injectors Market Size by Geographic Region (2018-2023)
4.1.1 Global On-body Injectors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global On-body Injectors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic On-body Injectors Market Size by Country/Region (2018-2023)
4.2.1 Global On-body Injectors Annual Sales by Country/Region (2018-2023)
4.2.2 Global On-body Injectors Annual Revenue by Country/Region (2018-2023)
4.3 Americas On-body Injectors Sales Growth
4.4 APAC On-body Injectors Sales Growth
4.5 Europe On-body Injectors Sales Growth
4.6 Middle East & Africa On-body Injectors Sales Growth
5 Americas
5.1 Americas On-body Injectors Sales by Country
5.1.1 Americas On-body Injectors Sales by Country (2018-2023)
5.1.2 Americas On-body Injectors Revenue by Country (2018-2023)
5.2 Americas On-body Injectors Sales by Type
5.3 Americas On-body Injectors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-body Injectors Sales by Region
6.1.1 APAC On-body Injectors Sales by Region (2018-2023)
6.1.2 APAC On-body Injectors Revenue by Region (2018-2023)
6.2 APAC On-body Injectors Sales by Type
6.3 APAC On-body Injectors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe On-body Injectors by Country
7.1.1 Europe On-body Injectors Sales by Country (2018-2023)
7.1.2 Europe On-body Injectors Revenue by Country (2018-2023)
7.2 Europe On-body Injectors Sales by Type
7.3 Europe On-body Injectors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa On-body Injectors by Country
8.1.1 Middle East & Africa On-body Injectors Sales by Country (2018-2023)
8.1.2 Middle East & Africa On-body Injectors Revenue by Country (2018-2023)
8.2 Middle East & Africa On-body Injectors Sales by Type
8.3 Middle East & Africa On-body Injectors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-body Injectors
10.3 Manufacturing Process Analysis of On-body Injectors
10.4 Industry Chain Structure of On-body Injectors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-body Injectors Distributors
11.3 On-body Injectors Customer
12 World Forecast Review for On-body Injectors by Geographic Region
12.1 Global On-body Injectors Market Size Forecast by Region
12.1.1 Global On-body Injectors Forecast by Region (2024-2029)
12.1.2 Global On-body Injectors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global On-body Injectors Forecast by Type
12.7 Global On-body Injectors Forecast by Application
13 Key Players Analysis
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Insulet
13.2.1 Insulet Company Information
13.2.2 Insulet On-body Injectors Product Portfolios and Specifications
13.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Insulet Main Business Overview
13.2.5 Insulet Latest Developments
13.3 Gerresheimer
13.3.1 Gerresheimer Company Information
13.3.2 Gerresheimer On-body Injectors Product Portfolios and Specifications
13.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Gerresheimer Main Business Overview
13.3.5 Gerresheimer Latest Developments
13.4 United Therapeutics
13.4.1 United Therapeutics Company Information
13.4.2 United Therapeutics On-body Injectors Product Portfolios and Specifications
13.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 United Therapeutics Main Business Overview
13.4.5 United Therapeutics Latest Developments
13.5 CC Bio
13.5.1 CC Bio Company Information
13.5.2 CC Bio On-body Injectors Product Portfolios and Specifications
13.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CC Bio Main Business Overview
13.5.5 CC Bio Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD On-body Injectors Product Portfolios and Specifications
13.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed On-body Injectors Product Portfolios and Specifications
13.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 Enable Injections
13.8.1 Enable Injections Company Information
13.8.2 Enable Injections On-body Injectors Product Portfolios and Specifications
13.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Enable Injections Main Business Overview
13.8.5 Enable Injections Latest Developments
13.9 Nemera
13.9.1 Nemera Company Information
13.9.2 Nemera On-body Injectors Product Portfolios and Specifications
13.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Nemera Main Business Overview
13.9.5 Nemera Latest Developments
13.10 Stevanato Group
13.10.1 Stevanato Group Company Information
13.10.2 Stevanato Group On-body Injectors Product Portfolios and Specifications
13.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Stevanato Group Main Business Overview
13.10.5 Stevanato Group Latest Developments
13.11 Sonceboz
13.11.1 Sonceboz Company Information
13.11.2 Sonceboz On-body Injectors Product Portfolios and Specifications
13.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sonceboz Main Business Overview
13.11.5 Sonceboz Latest Developments
13.12 Lohmann Therapie-Systeme
13.12.1 Lohmann Therapie-Systeme Company Information
13.12.2 Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
13.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lohmann Therapie-Systeme Main Business Overview
13.12.5 Lohmann Therapie-Systeme Latest Developments
13.13 Elcam Drug Delivery Devices (E3D)
13.13.1 Elcam Drug Delivery Devices (E3D) Company Information
13.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
13.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Elcam Drug Delivery Devices (E3D) Main Business Overview
13.13.5 Elcam Drug Delivery Devices (E3D) Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global On-body Injectors market size was valued at US$ 140.9 million in 2022. With growing demand in downstream market, the On-body Injectors is forecast to a readjusted size of US$ 387.7 million by 2029 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global On-body Injectors market. On-body Injectors are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of On-body Injectors. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the On-body Injectors market.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
Key Features:
The report on On-body Injectors market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the On-body Injectors market. It may include historical data, market segmentation by Type (e.g., Electronic Injectors, Mechanical Injectors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the On-body Injectors market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the On-body Injectors market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the On-body Injectors industry. This include advancements in On-body Injectors technology, On-body Injectors new entrants, On-body Injectors new investment, and other innovations that are shaping the future of On-body Injectors.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the On-body Injectors market. It includes factors influencing customer ' purchasing decisions, preferences for On-body Injectors product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the On-body Injectors market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting On-body Injectors market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the On-body Injectors market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the On-body Injectors industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the On-body Injectors market.
Market Segmentation:
On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Electronic Injectors
Mechanical Injectors
Segmentation by application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Key Questions Addressed in this Report
What is the 10-year outlook for the global On-body Injectors market?
What factors are driving On-body Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do On-body Injectors market opportunities vary by end market size?
How does On-body Injectors break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global On-body Injectors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for On-body Injectors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for On-body Injectors by Country/Region, 2018, 2022 & 2029
2.2 On-body Injectors Segment by Type
2.2.1 Electronic Injectors
2.2.2 Mechanical Injectors
2.3 On-body Injectors Sales by Type
2.3.1 Global On-body Injectors Sales Market Share by Type (2018-2023)
2.3.2 Global On-body Injectors Revenue and Market Share by Type (2018-2023)
2.3.3 Global On-body Injectors Sale Price by Type (2018-2023)
2.4 On-body Injectors Segment by Application
2.4.1 Immuno-oncology
2.4.2 Cardiovascular Diseases
2.4.3 Neurological Diseases
2.4.4 Others
2.5 On-body Injectors Sales by Application
2.5.1 Global On-body Injectors Sale Market Share by Application (2018-2023)
2.5.2 Global On-body Injectors Revenue and Market Share by Application (2018-2023)
2.5.3 Global On-body Injectors Sale Price by Application (2018-2023)
3 Global On-body Injectors by Company
3.1 Global On-body Injectors Breakdown Data by Company
3.1.1 Global On-body Injectors Annual Sales by Company (2018-2023)
3.1.2 Global On-body Injectors Sales Market Share by Company (2018-2023)
3.2 Global On-body Injectors Annual Revenue by Company (2018-2023)
3.2.1 Global On-body Injectors Revenue by Company (2018-2023)
3.2.2 Global On-body Injectors Revenue Market Share by Company (2018-2023)
3.3 Global On-body Injectors Sale Price by Company
3.4 Key Manufacturers On-body Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers On-body Injectors Product Location Distribution
3.4.2 Players On-body Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for On-body Injectors by Geographic Region
4.1 World Historic On-body Injectors Market Size by Geographic Region (2018-2023)
4.1.1 Global On-body Injectors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global On-body Injectors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic On-body Injectors Market Size by Country/Region (2018-2023)
4.2.1 Global On-body Injectors Annual Sales by Country/Region (2018-2023)
4.2.2 Global On-body Injectors Annual Revenue by Country/Region (2018-2023)
4.3 Americas On-body Injectors Sales Growth
4.4 APAC On-body Injectors Sales Growth
4.5 Europe On-body Injectors Sales Growth
4.6 Middle East & Africa On-body Injectors Sales Growth
5 Americas
5.1 Americas On-body Injectors Sales by Country
5.1.1 Americas On-body Injectors Sales by Country (2018-2023)
5.1.2 Americas On-body Injectors Revenue by Country (2018-2023)
5.2 Americas On-body Injectors Sales by Type
5.3 Americas On-body Injectors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC On-body Injectors Sales by Region
6.1.1 APAC On-body Injectors Sales by Region (2018-2023)
6.1.2 APAC On-body Injectors Revenue by Region (2018-2023)
6.2 APAC On-body Injectors Sales by Type
6.3 APAC On-body Injectors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe On-body Injectors by Country
7.1.1 Europe On-body Injectors Sales by Country (2018-2023)
7.1.2 Europe On-body Injectors Revenue by Country (2018-2023)
7.2 Europe On-body Injectors Sales by Type
7.3 Europe On-body Injectors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa On-body Injectors by Country
8.1.1 Middle East & Africa On-body Injectors Sales by Country (2018-2023)
8.1.2 Middle East & Africa On-body Injectors Revenue by Country (2018-2023)
8.2 Middle East & Africa On-body Injectors Sales by Type
8.3 Middle East & Africa On-body Injectors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of On-body Injectors
10.3 Manufacturing Process Analysis of On-body Injectors
10.4 Industry Chain Structure of On-body Injectors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 On-body Injectors Distributors
11.3 On-body Injectors Customer
12 World Forecast Review for On-body Injectors by Geographic Region
12.1 Global On-body Injectors Market Size Forecast by Region
12.1.1 Global On-body Injectors Forecast by Region (2024-2029)
12.1.2 Global On-body Injectors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global On-body Injectors Forecast by Type
12.7 Global On-body Injectors Forecast by Application
13 Key Players Analysis
13.1 West Pharmaceutical Services
13.1.1 West Pharmaceutical Services Company Information
13.1.2 West Pharmaceutical Services On-body Injectors Product Portfolios and Specifications
13.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 West Pharmaceutical Services Main Business Overview
13.1.5 West Pharmaceutical Services Latest Developments
13.2 Insulet
13.2.1 Insulet Company Information
13.2.2 Insulet On-body Injectors Product Portfolios and Specifications
13.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Insulet Main Business Overview
13.2.5 Insulet Latest Developments
13.3 Gerresheimer
13.3.1 Gerresheimer Company Information
13.3.2 Gerresheimer On-body Injectors Product Portfolios and Specifications
13.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Gerresheimer Main Business Overview
13.3.5 Gerresheimer Latest Developments
13.4 United Therapeutics
13.4.1 United Therapeutics Company Information
13.4.2 United Therapeutics On-body Injectors Product Portfolios and Specifications
13.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 United Therapeutics Main Business Overview
13.4.5 United Therapeutics Latest Developments
13.5 CC Bio
13.5.1 CC Bio Company Information
13.5.2 CC Bio On-body Injectors Product Portfolios and Specifications
13.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CC Bio Main Business Overview
13.5.5 CC Bio Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD On-body Injectors Product Portfolios and Specifications
13.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed On-body Injectors Product Portfolios and Specifications
13.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 Enable Injections
13.8.1 Enable Injections Company Information
13.8.2 Enable Injections On-body Injectors Product Portfolios and Specifications
13.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Enable Injections Main Business Overview
13.8.5 Enable Injections Latest Developments
13.9 Nemera
13.9.1 Nemera Company Information
13.9.2 Nemera On-body Injectors Product Portfolios and Specifications
13.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Nemera Main Business Overview
13.9.5 Nemera Latest Developments
13.10 Stevanato Group
13.10.1 Stevanato Group Company Information
13.10.2 Stevanato Group On-body Injectors Product Portfolios and Specifications
13.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Stevanato Group Main Business Overview
13.10.5 Stevanato Group Latest Developments
13.11 Sonceboz
13.11.1 Sonceboz Company Information
13.11.2 Sonceboz On-body Injectors Product Portfolios and Specifications
13.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sonceboz Main Business Overview
13.11.5 Sonceboz Latest Developments
13.12 Lohmann Therapie-Systeme
13.12.1 Lohmann Therapie-Systeme Company Information
13.12.2 Lohmann Therapie-Systeme On-body Injectors Product Portfolios and Specifications
13.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lohmann Therapie-Systeme Main Business Overview
13.12.5 Lohmann Therapie-Systeme Latest Developments
13.13 Elcam Drug Delivery Devices (E3D)
13.13.1 Elcam Drug Delivery Devices (E3D) Company Information
13.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolios and Specifications
13.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Elcam Drug Delivery Devices (E3D) Main Business Overview
13.13.5 Elcam Drug Delivery Devices (E3D) Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/05 10:26

153.43 円

167.28 円

201.52 円

ページTOPに戻る